New pages
- 11:55, 22 January 2020 Luspatercept (Reblozyl) (hist) [1,095 bytes] Jwarner (talk | contribs) (Created page with "==Mechanism of action== From the NCI Drug Dictionary: A soluble, recombinant fusion protein composed of a modified form of the extracellular domain of human activin receptor t...")
- 18:44, 10 January 2020 Avapritinib (Ayvakit) (hist) [2,233 bytes] Jwarner (talk | contribs) (Created page with "==General information== Class/mechanism from the [https://www.cancer.gov/publications/dictionaries/cancer-drug/def/pdgfr-alpha-kit-mutant-specific-inhibitor-blu-285 NCI Drug D...")
- 00:43, 10 January 2020 Regimen classes (hist) [706 bytes] Jwarner (talk | contribs) (Created page with "''The purpose of this page is to define regimen classes that will be used in the HemOnc vocabulary; it is not for other purposes at this time.'' =Endocrine-based regimen= =Ir...")
- 17:20, 8 January 2020 Biomarkers (hist) [7,488 bytes] Jwarner (talk | contribs) (Created page with "=Genes= =Alterations= ==Structural variant== ===Copy number variation=== ====Amplification==== ====Deletion==== ===Insertion=== ==Expression== ===Overexpression=== ===Un...")
- 00:32, 8 January 2020 Ovarian cancer, BRCA-mutated (hist) [10,643 bytes] Jwarner (talk | contribs) (Created page with "{| class="wikitable" style="text-align:center; width:50%;" !colspan="2" align="center" style="color:white; font-size:125%; background-color:#08519c"|'''Section editor''' |- |s...")
- 12:09, 7 January 2020 Pancreatic cancer, BRCA-mutated (hist) [6,450 bytes] Jwarner (talk | contribs) (Created page with "{| class="wikitable" style="text-align:center; width:100%;" ! colspan="2" align="center" style="color:white; font-size:125%; background-color:#08519c" |'''Page editor''' ! col...")
- 11:26, 7 January 2020 Non-small cell lung cancer, KRAS-mutated (hist) [4,359 bytes] Jwarner (talk | contribs) (Created page with "{| class="wikitable" style="text-align:center; width:50%;" !colspan="2" align="center" style="color:white; font-size:125%; background-color:#08519c"|'''Section editor''' |- |s...")
- 12:39, 6 January 2020 Melanoma, KIT-mutated (hist) [3,967 bytes] Jwarner (talk | contribs) (Created page with "{| class="wikitable" style="text-align:center; width:50%;" !colspan="2" align="center" style="color:white; font-size:125%; background-color:#08519c"|'''Section editor''' |- |s...")
- 17:37, 24 December 2019 Breast cancer, HER2-positive - historical (hist) [30,789 bytes] Jwarner (talk | contribs) (Created page with "The purpose of this page is to provide references to regimens that are obsolete, outdated, or of historical interest only. As a general rule, this includes the inferior arm(s)...")
- 22:26, 20 December 2019 Fam-trastuzumab deruxtecan (Enhertu) (hist) [2,528 bytes] Jwarner (talk | contribs) (Created page with "==General information== Class/mechanism from the [https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-her2-adc-ds-8201a NCI Drug Dictionary]: An antibody-dru...")
- 12:09, 19 December 2019 Enfortumab vedotin (Padcev) (hist) [2,279 bytes] Jwarner (talk | contribs) (Created page with "==General information== Class/mechanism from the [https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-nectin-4-antibody-drug-conjugate-asg-22ce NCI Drug Dict...")
- 23:03, 15 November 2019 Zanubrutinib (Brukinsa) (hist) [1,267 bytes] Jwarner (talk | contribs) (Created page with "==General information== Class/mechanism: BTK inhibitor <br>Route: PO <br>Extravasation: n/a For conciseness and simplicity, HemOnc.org currently will focus on treatment regim...")
- 12:36, 14 November 2019 Antimicrobial prophylaxis (hist) [1,088 bytes] Jwarner (talk | contribs) (Created page with "This is a stub page that will be expanded over time =Guidelines= ==ASCO/IDSA== * '''2018:''' Taplitz et al. [https://ascopubs.org/doi/full/10.1200/JCO.18.00374 Antimicrobial...")
- 07:30, 8 November 2019 Experimental design (hist) [3,607 bytes] Jwarner (talk | contribs) (Created page with "{| class="wikitable" style="text-align:center; width:50%;" !colspan="2" align="center" style="color:white; font-size:125%; background-color:#4a1486"|'''Section editor''' |- |s...")
- 18:57, 6 November 2019 Colon cancer, HER2-positive (hist) [8,275 bytes] Ryannguyen (talk | contribs) (Created page with "{| class="wikitable" style="text-align:center; width:50%;" !colspan="2" align="center" style="color:white; font-size:125%; background-color:#08519c"|'''Section editor''' |- |s...") originally created as "Colon cancer, Her2-amplified"
- 21:12, 2 November 2019 Smoldering multiple myeloma (hist) [17,004 bytes] Jwarner (talk | contribs) (Created page with "{| class="wikitable" style="text-align:center; width:100%;" ! colspan="2" align="center" style="color:white; font-size:125%; background-color:#de2d26" |'''Page editor''' ! col...")
